Novo Nordisk A/S

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment pro…

Biotechnology

DK, Bagsvaerd [HQ]

Overview
Fin. Reports
Financials
Leadership & Strategy
Government, Law & Regulation
Employees
More

Lobbying · US Senate · Influence

Lobbying Analysis

Lobbying · US Senate · Influence

Here you'll find all expenses made over the past 12M of Novo Nordisk A/S to fulfill lobbying activities in the United States of America.

FY	Quarter	Lobby Expense [in mil. $]	Filing	Report Time
2024	2	2	LDA-2	July 19, 2024, 5:42 p.m.